A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to
Continue reading »
Home »
New findings may help oncologists determine effectiveness of checkpoint inhibitors
In an article recently published in JCI Insight, researchers from the University of Alabama at Birmingham and Vanderbilt University have
Continue reading »
Myocarditis rare side effect of immune checkpoint inhibitors
(HealthDay)—Myocarditis in patients treated with immune checkpoint inhibitors (ICIs) may be more common than previously thought, according to a study
Continue reading »